Carbapenem versus cefepime or piperacillin-tazobactam for empiric treatment of bacteremia due to extended-spectrum-lactamase-producing Escherichia coli in patients with hematologic malignancy

Grace E. Benanti, Anne Rain T. Brown, Terri Lynn Shigle, Jeffrey J. Tarrand, Micah M. Bhatti, Patrick M. McDaneld, Samuel A. Shelburne, Samuel L. Aitken

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Carbapenem versus cefepime or piperacillin-tazobactam for empiric treatment of bacteremia due to extended-spectrum-lactamase-producing Escherichia coli in patients with hematologic malignancy'. Together they form a unique fingerprint.

Medicine & Life Sciences